CARTER COPELAND: Open Payments
NPI 1003560939 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,497 in 263 payments from 39 companies in 2025. Trend: 2023 $3,921 · 2024 $5,211 · 2025 $5,497
Food & beverage: $5,398Education: $99
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 44 | $994 |
| ABBVIE INC. | 36 | $488 |
| Biogen, Inc. | 14 | $334 |
| Lundbeck LLC | 11 | $316 |
| Teva Pharmaceuticals USA, Inc. | 13 | $277 |
| PFIZER INC. | 18 | $263 |
| Neurelis, Inc. | 14 | $244 |
| Janssen Biotech, Inc. | 5 | $186 |
| TG Therapeutics, Inc. | 8 | $177 |
| Lilly USA, LLC | 13 | $170 |
Products named: Zilbrysq, LEQEMBI, VYEPTI, AUSTEDO XR, NURTEC ODT, VALTOCO, QULIPTA, UBRELVY.
Industry payments across CA — which companies pay providers there.
